Pravastatin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pravastatin
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Pravastatin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 16 USDMF, 12 CEP/COS, 9 JDMF, 3 EU WC, 9 KDMF, 5 NDC API, 9 Listed Suppliers, $ API Reference Price

26 API Suppliers
16 USDMF
12 CEP/COS
9 JDMF
3 EU WC
9 KDMF
5 NDC API
9 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

448 FDF Dossiers, 78 FDA Orange Book, 234 Europe, 51 Canada, 42 Australia, 27 South Africa, 16 Listed Dossiers

448 FDF Dossiers
78 FDA Orange Book
234 Europe
51 Canada
42 Australia
27 South Africa
16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 24 SPI Pharma, 3 DKSH, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 ACG Worldwide, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 11 Corel Pharma Chem, 6 DFE Pharma, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 39 Direct Compression, 37 Disintegrants & Superdisintegrants, 30 Granulation, 27 Lubricants & Glidants, 24 Controlled & Modified Release, 21 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 19 Thickeners and Stabilizers, 18 Taste Masking, 15 Solubilizers, 9 Film Formers & Plasticizers, 9 API Stability Enhancers, 9 Parenteral, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Topical, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

85 Fillers, Diluents & Binders
47 Coating Systems & Additives
39 Direct Compression
37 Disintegrants & Superdisintegrants
30 Granulation
27 Lubricants & Glidants
24 Controlled & Modified Release
21 Chewable & Orodispersible Aids
19 Co-Processed Excipients
19 Thickeners and Stabilizers
18 Taste Masking
15 Solubilizers
9 Film Formers & Plasticizers
9 API Stability Enhancers
9 Parenteral
6 Emulsifying Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
3 Topical
3 Rheology Modifiers
2 Surfactant & Foaming Agents

DIGITAL CONTENT

20 NEWS #PharmaBuzz

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 228 Finished Drug Prices, 1 Annual Reports

1 US Medicaid Prescriptions
228 Finished Drug Prices
1 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 6 JP, 5 Others

3 EDQM
4 USP
6 JP
5 Others

$ API Ref.Price (USD/KG) : 619 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling Lafleur Henderson LLP

filter Patent Reset all filters

4 All

01 41323836

filter Product Reset all filters

4 All

01 4Pravastatin Sodium

filter Dosage Reset all filters

4 All

01 3Tablet

02 1Tablets

filter Exp Date Reset all filters

4 All

01 42010-11-02

Product Main Page

01

Gowling Lafleur Henderson LLP

Pravastatin

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 10mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Pravastatin

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Pravastatin

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 40mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Lafleur Henderson LLP

Pravastatin

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 80 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!